XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
2.160
+0.030 (1.41%)
At close: Oct 2, 2026, 4:00 PM EDT
2.150
-0.010 (-0.46%)
After-hours: Oct 2, 2026, 4:10 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $8.16 million as of October 2, 2026. Its market cap has decreased by -23.40% in one year.
Market Cap
8.16M
Enterprise Value
8.08M
1-Year Change
-23.40%
Ranking
Category
Stock Price
$2.16
ChartMarket Cap Chart
Since September 1, 2005, XTL Biopharmaceuticals's market cap has decreased from $190.39M to $8.16M, a decrease of -95.72%. That is a compound annual growth rate of -13.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 8.16M | 14.49% |
| Dec 31, 2025 | 7.12M | -68.18% |
| Dec 31, 2024 | 22.38M | 322.69% |
| Dec 31, 2023 | 5.30M | -16.54% |
| Dec 29, 2022 | 6.35M | -57.67% |
| Dec 30, 2021 | 14.99M | -4.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Enlivex | 8.42M |
| FibroBiologics | 8.38M |
| Traws Pharma | 8.38M |
| Longeveron | 8.26M |
| KALA BIO | 8.11M |
| Soligenix | 7.92M |
| Azitra | 7.79M |
| Ensysce Biosciences | 7.78M |